• Company
    • About Us
    • Partnerships
    • Board & Teams
  • Technologies
    • Natural Killer Cells
    • Mesenchymal Stromal Cells
  • Pipeline
  • News
    • Press Releases
    • In The Press
    • Articles
  • Careers
  • Contact
Menu
  • Company
    • About Us
    • Partnerships
    • Board & Teams
  • Technologies
    • Natural Killer Cells
    • Mesenchymal Stromal Cells
  • Pipeline
  • News
    • Press Releases
    • In The Press
    • Articles
  • Careers
  • Contact

MedXCell SA is proud to annonce the arrival of Andrew Galzaka and John D. McMannis as new members of the Board and Pierre J.Magistretti as new scientific advisor

Montreux, Switzerland | March 11, 2022 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and

Read More »

MedXCell SA is pleased to announce the appointment of Dr Jean-Jacques de Dardel as a member of the Board of Directors.

Montreux, Switzerland | August 26, 2021 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and accessible new

Read More »

MedXCell SA has successfully closed a CHF 5.3 million Series A

Montreux, Switzerland | June 4, 2021 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and

Read More »

MedXCell SA is proud to announce the arrival of Gabriel Baertschi as a new member of the Board

Montreux, Switzerland | May 17, 2021 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and

Read More »

The MedXCell Group proudly participate in the Med Vallée project of the city of Montpellier, France

Montreux, Switzerland | April 27, 2021 – The MedXCell Group is proud to announce its participation in the Med Vallée project. This European scale project aims

Read More »

The MedXCell Group is proud to announce the historic entry of the University of Montpellier into the capital of MedXCell Science

Montreux, Switzerland | April 14, 2021 – The MedXCell Group is proud to announce the historic entry of the University of Montpellier (UM) into the

Read More »
Page1 Page2

Montreux, CH – Montpellier, FR – Cambridge MA, USA

Linkedin

This website contains information about products that may not be available in all countries, available under different trademarks or for different indications. Nothing contained herein should be considered a solicitation, promotion or advertisement for any product including those under development and described on this site. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider

© All rights reserved 2021 – MedXCell SA